These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7209044)

  • 1. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
    García Hierro P; Ponte Miramontes MC; Soriano García F
    Rev Clin Esp; 1980 Oct; 159(2):87-90. PubMed ID: 7209044
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J; Thomas M; Shanmugam J
    Indian J Pathol Microbiol; 1985 Apr; 28(2):115-9. PubMed ID: 3835114
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
    Kazmierczak A; Gailliard MC; Pothier P; Siebor E; Portier H
    Nouv Presse Med; 1979 Oct; 8(42):3399-402. PubMed ID: 537884
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activity of various semisynthetic aminoglycoside antibiotics on gentamicin-sensitive and gentamicin-resistant bacterial populations].
    Zemelman R; Bello H; Mondaca MA
    Rev Med Chil; 1983 Mar; 111(3):255-61. PubMed ID: 6648106
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amikacin in the treatment of Gram negative bacilli septicemias].
    Cartier F; Dien G; Cormier M; Hoel JC; Guivarch G
    Nouv Presse Med; 1979 Oct; 8(42):3510-12. PubMed ID: 537908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
    Linda H; Patzer J
    Med Dosw Mikrobiol; 1984; 36(4):223-9. PubMed ID: 6100122
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study of Amikacin (BB-K8) and gentamicin activity in vitro against Proteus rettgeri.
    Pérez-Rodríguez F; Bermúdez RH; de Brau CJ
    Bol Asoc Med P R; 1977 Jul; 69(7):222-6. PubMed ID: 268183
    [No Abstract]   [Full Text] [Related]  

  • 8. Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates.
    Forgan-Smith WR; McSweeney RJ
    Aust N Z J Med; 1978 Aug; 8(4):383-6. PubMed ID: 282852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
    Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological characteristics of kanendomycin].
    Blandino G; Mattina R; Speciale A; Toscano MA
    G Ital Chemioter; 1977; 24(1-2):7-10. PubMed ID: 615765
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and characterization of mutants of Escherichia coli K12 resistant to the new aminoglycoside antibiotic, amikacin.
    Hull R; Klinger JD; Moody EE
    J Gen Microbiol; 1976 Jun; 94(2):389-94. PubMed ID: 781182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro amikacin sensitivity testing.
    Vaidya AK; Salvekar PM; Wagle NM; Merchant SM
    Indian Pediatr; 1986 Jun; 23(6):415-8. PubMed ID: 3744520
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals].
    Witchitz JL; Golstein FW; Pangon B; Christol D; Acar JF
    Nouv Presse Med; 1979 Oct; 8(42):3417-20. PubMed ID: 537886
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin.
    Kabins SA; Nathan C
    Antimicrob Agents Chemother; 1978 Nov; 14(5):786-7. PubMed ID: 727766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UK-18892, a new aminoglycoside: an in vitro study.
    Wise R; Andrews JM
    Antimicrob Agents Chemother; 1978 Aug; 14(2):228-33. PubMed ID: 100050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 17. Amikacin.
    Gleckman R
    Am Fam Physician; 1976 Dec; 14(6):75. PubMed ID: 998471
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection of the phenotypes of resistance of enterobacteriaceae to aminoglycosides with ATB Plus Expert System].
    Peyret M; Albertini MT; Olleon M; Davenas C; Blanc V
    Pathol Biol (Paris); 1993 Apr; 41(4):329-36. PubMed ID: 8233631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The antibacterial activity of amikacin in comparison with four other aminoglycoside antibiotics (proceedings)].
    Schassan HH
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):320-8. PubMed ID: 983520
    [No Abstract]   [Full Text] [Related]  

  • 20. Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.
    Glew RH; Pavuk RA
    Antimicrob Agents Chemother; 1984 Sep; 26(3):378-81. PubMed ID: 6508266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.